Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- Fifth-gen BMW X5 unveiled with 5 different powertrains
- Legionnaires’ outbreak: 31 NYC cooling towers test positive for Legionella bacteria
- Delta Battery conducts site establishment during operational readiness exercise
- Master Gardeners cultivate healthy habits in young students
- Scientists discover the one nutrient beneficial parasites can't live without
- Guarding the Body’s Water Purifier: Seven Lifestyle Habits to Protect Your Kidneys
- Vertex acquires Crinetics in $10bn endocrinology deal
- U.S., Chile, partners wrap up Exercise Salitre 2026
Browsing: Weight Loss
Eli Lilly (NYSE: LLY) is a Wall Street darling thanks to its success in the GLP-1 weight-loss market. There’s a problem here, however, because weight-loss drugs now account for nearly two-thirds of the drug maker’s revenues. Johnson & Johnson (NYSE: JNJ) CEO Joaquin Duato isn’t interested in being so reliant on just one healthcare niche.…
Think about how you handled a bad day at 19. Now think about how you handle one at 35. You are the same person, but your reaction has changed completely with time. What used to work doesn’t anymore, and you’ve adjusted without even noticing. The same logic applies to your nutrition. What worked for you…
Novo Nordisk A/S (DK0062498333) remains one of the most closely followed global drugmakers, with its business built around diabetes and obesity therapies. The company is listed in Copenhagen and its shares are watched through the lens of U.S. healthcare peers, a useful reference point for American investors
Zepbound from Eli Lilly & Co. sits in a pharmacist’s refrigerator behind a glass door, its slim injection pens lined up like muted blue markers ready for Sunday night routines. In New York, an endocrinologist told me patients now set calendar alerts for their weekly dose. The vibe is practical, not glamorous, but the weight-loss…
July 5, 2026 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces today recent submissions of two Investigational New Drug (IND) applications to the U.S. Food and Drug Administration (FDA) for ASC36, a once-monthly to once-quarterly next-generation peptide amylin receptor agonist and ASC36_35 FDC, a once-monthly injection co-formulation of ASC36 plus peptide GLP-1R/GIPR agonist ASC35,…
Country music singer Nate Smith is sharing a new update on his continuing weight loss journey
Amy Schumeris celebrating the 4th of July in style after opening up about her weight loss journey
Babies exposed to higher levels of neurotoxin more likely to have difficulty controlling impulses later, research shows
The country music singer and TikTok sensation, who previously opened up about his battle with binge eating, shared his progress on his weight loss journey in a new interview with People magazine published Saturday, July 4

